A dose-escalation and safety gene therapy study in a model of CMT4C neuropathy.

Georgiou E, Kagiava A, Hentschel A, Sargiannidou I, Papacharalampous R, Stavrou M, Tryfonos C, Richter J, Roos A, Kleopa KA